NO20024222D0 - Farmasöytiske forbindelser - Google Patents
Farmasöytiske forbindelserInfo
- Publication number
- NO20024222D0 NO20024222D0 NO20024222A NO20024222A NO20024222D0 NO 20024222 D0 NO20024222 D0 NO 20024222D0 NO 20024222 A NO20024222 A NO 20024222A NO 20024222 A NO20024222 A NO 20024222A NO 20024222 D0 NO20024222 D0 NO 20024222D0
- Authority
- NO
- Norway
- Prior art keywords
- cannabis
- hfc
- formulation
- derivatives
- synthetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/44—Valves specially adapted therefor; Regulating devices
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0005718A GB2361869B (en) | 2000-03-09 | 2000-03-09 | Sublingual delivery of cannabis |
GB0101743A GB0101743D0 (en) | 2001-01-23 | 2001-01-23 | pharmaceutical compositions |
GB0101744A GB0101744D0 (en) | 2001-01-23 | 2001-01-23 | Pharmaceutical compositions |
PCT/GB2001/001027 WO2001066089A2 (en) | 2000-03-09 | 2001-03-09 | Pharmaceutical compositions comprising cannabis |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20024222D0 true NO20024222D0 (no) | 2002-09-04 |
NO20024222L NO20024222L (no) | 2002-11-06 |
NO332663B1 NO332663B1 (no) | 2012-11-26 |
Family
ID=27255586
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024222A NO332663B1 (no) | 2000-03-09 | 2002-09-04 | Anvendelese av cannabis, et væskeekstrakt eller delta-9-tatrahydrocannabinol eller et farmasøytisk derivat derav for terapeutisk behandling av en pasient vi den sublinguale rute, og pumpesparyanordning |
NO2013011C NO2013011I2 (no) | 2000-03-09 | 2013-05-24 | En blanding av to ekstrakter fra Cannabis sativa L., folicum cum flore (cannabisblad og -blomst). |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2013011C NO2013011I2 (no) | 2000-03-09 | 2013-05-24 | En blanding av to ekstrakter fra Cannabis sativa L., folicum cum flore (cannabisblad og -blomst). |
Country Status (22)
Country | Link |
---|---|
US (5) | US20030191180A1 (no) |
EP (1) | EP1280515B1 (no) |
JP (1) | JP5599961B2 (no) |
KR (1) | KR20030038536A (no) |
CN (1) | CN1258359C (no) |
AT (1) | ATE353629T1 (no) |
AU (1) | AU782991B2 (no) |
CA (1) | CA2402020C (no) |
CY (1) | CY1106549T1 (no) |
CZ (1) | CZ303537B6 (no) |
DE (2) | DE60126599T2 (no) |
DK (1) | DK1280515T3 (no) |
ES (1) | ES2280343T3 (no) |
HU (1) | HU228237B1 (no) |
IL (2) | IL151603A0 (no) |
MX (1) | MXPA02008778A (no) |
NO (2) | NO332663B1 (no) |
NZ (1) | NZ544681A (no) |
PL (1) | PL202673B1 (no) |
PT (1) | PT1280515E (no) |
SI (1) | SI1280515T1 (no) |
WO (1) | WO2001066089A2 (no) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040141923A1 (en) * | 1997-10-01 | 2004-07-22 | Dugger Harry A. | Buccal, polar and non-polar spray containing alprazolam |
US20030095925A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
US20050180923A1 (en) * | 1997-10-01 | 2005-08-18 | Dugger Harry A.Iii | Buccal, polar and non-polar spray containing testosterone |
US20050287075A1 (en) * | 1997-10-01 | 2005-12-29 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
US20030082107A1 (en) * | 1997-10-01 | 2003-05-01 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
US20030190286A1 (en) * | 1997-10-01 | 2003-10-09 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
US20050002867A1 (en) * | 1997-10-01 | 2005-01-06 | Novadel Pharma Inc. | Buccal, polar and non-polar sprays containing propofol |
US20040136915A1 (en) * | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing atropine |
US20030185761A1 (en) | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
US20030077229A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
US20030095926A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
US20050163719A1 (en) * | 1997-10-01 | 2005-07-28 | Dugger Harry A.Iii | Buccal, polar and non-polar spray containing diazepam |
US20040136914A1 (en) * | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
US7632517B2 (en) * | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
US20030077227A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US20050281752A1 (en) * | 1997-10-01 | 2005-12-22 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US20030077228A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders |
US20030095927A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
EP1029536B1 (en) * | 1997-10-01 | 2007-11-28 | Novadel Pharma Inc. | Buccal non-polar spray |
CZ303537B6 (cs) | 2000-03-09 | 2012-11-21 | Gw Pharma Limited | Použití konopí pri príprave farmaceutické formulace a pumpickové sprejové zarízení |
US10004684B2 (en) | 2001-02-14 | 2018-06-26 | Gw Pharma Limited | Pharmaceutical formulations |
EP2292211A3 (en) * | 2001-02-14 | 2014-01-01 | GW Pharma Limited | Mucoadhesive pharmaceutical formulations |
US6730330B2 (en) | 2001-02-14 | 2004-05-04 | Gw Pharma Limited | Pharmaceutical formulations |
GB0103638D0 (en) * | 2001-02-14 | 2001-03-28 | Gw Pharmaceuticals Ltd | Pharmaceutical formulations |
GB2384184B (en) * | 2002-01-10 | 2005-01-12 | Aea Technology Plc | Cannabis aerosol |
EP1340492A1 (en) * | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
SI1542657T1 (sl) | 2002-08-14 | 2012-04-30 | Gw Pharma Ltd | Kanabinoidne kapljevite formulacije za sluzniäśno administracijo |
EP1827393A4 (en) * | 2004-12-09 | 2012-04-18 | Insys Therapeutics Inc | DRONABINOL FORMULATIONS WITH LABORATORY TEMPERATURE |
EP1855666A1 (en) * | 2005-02-25 | 2007-11-21 | Unimed Pharmaceuticals, Inc. | Dronabinol compositions and methods of using same |
ES2357250T3 (es) * | 2005-06-16 | 2011-04-20 | Euro-Celtique S.A. | Composiciones que comprenden trans-(+/-)-delta-9-tetrahidrocannabinol cristalino. |
CA2612019A1 (en) * | 2005-06-20 | 2007-01-04 | Unimed Pharmaceuticals, Inc. | Dronabinol treatment for migraines |
US7851419B2 (en) * | 2005-09-12 | 2010-12-14 | Nawaz Ahmad | Substantially anhydrous sprayable personal lubricant |
DK1903866T3 (en) * | 2005-11-07 | 2016-07-25 | Murty Pharmaceuticals Inc | Improved release of tetrahydrocannabinol |
CA2649895C (en) * | 2006-04-19 | 2013-03-26 | Novadel Pharma Inc. | Stable hydroalcoholic oral spray formulations and methods |
AU2007281918A1 (en) * | 2006-08-04 | 2008-02-14 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
EP2124897A4 (en) * | 2006-12-22 | 2012-05-09 | Novadel Pharma Inc | SPRAYING, ORAL, STABLE, SPRAY PREPARATIONS AND ASSOCIATED METHODS |
JP2010526837A (ja) * | 2007-05-10 | 2010-08-05 | ノヴァデル ファーマ インコーポレイテッド | 抗不眠症組成物および方法 |
US9035130B2 (en) | 2007-05-31 | 2015-05-19 | Gw Pharma Limited | Reference plant, a method for its production, extracts obtained therefrom and their use |
EP2184983A1 (en) * | 2007-08-06 | 2010-05-19 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
US8222292B2 (en) | 2007-08-06 | 2012-07-17 | Insys Therapeutics, Inc. | Liquid cannabinoid formulations |
US8801436B2 (en) * | 2008-04-02 | 2014-08-12 | Carson Laboraotories, I, P., Inc. | Oral hygiene composition and apparatus and method |
AT509000B1 (de) * | 2009-10-23 | 2012-12-15 | Rausch Peter | Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen |
US8445034B1 (en) | 2010-11-02 | 2013-05-21 | Albert L Coles, Jr. | Systems and methods for producing organic cannabis tincture |
US10265293B2 (en) | 2012-10-04 | 2019-04-23 | Insys Development Company, Inc. | Oral cannabinoid formulations |
US11253472B2 (en) | 2012-10-04 | 2022-02-22 | Benuvia Therapeutics Llc | Oral cannabinoid formulations |
US9345771B2 (en) | 2012-10-04 | 2016-05-24 | Insys Development Company, Inc. | Oral cannabinoid formulations |
US9532593B2 (en) | 2013-12-26 | 2017-01-03 | John Turner | Herbal smoking blend |
US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
GB2524469A (en) * | 2014-02-14 | 2015-09-30 | Kind Consumer Ltd | A cannabinoid inhaler and composition therefor |
US9918961B2 (en) | 2014-02-19 | 2018-03-20 | Kind Consumer Limited | Cannabinoid inhaler and composition therefor |
BR112016010475B1 (pt) * | 2014-03-13 | 2021-07-20 | Stevanato Group International A.S. | Método de manuseio de uma formulação farmacêutica líquida |
US10307446B2 (en) | 2014-03-21 | 2019-06-04 | St&T International, Inc. | Cannabis extraction method and compositions |
EP3125979B1 (en) * | 2014-03-31 | 2022-07-13 | Boehringer Ingelheim Vetmedica GmbH | Inhaler |
AU2015280412B2 (en) | 2014-06-26 | 2018-07-26 | Island Breeze Systems Ca, Llc | MDI related products and methods of use |
AU2015292915B2 (en) | 2014-07-21 | 2020-10-15 | Pharmaceutical Productions, Inc. | Solid dosage form composition for buccal or sublingual administration of cannabinoids |
US9565865B2 (en) | 2014-08-15 | 2017-02-14 | Imbue LLC | Method for making coffee products containing cannabis ingredients |
US10897915B2 (en) | 2014-08-15 | 2021-01-26 | Blacklist Holdings, Inc. | Method for making coffee products containing cannabis ingredients |
US11793769B2 (en) | 2014-08-25 | 2023-10-24 | Jai Shankar Sukul | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
US10143706B2 (en) | 2016-06-29 | 2018-12-04 | Cannscience Innovations, Inc. | Decarboxylated cannabis resins, uses thereof and methods of making same |
US9717683B1 (en) | 2016-06-29 | 2017-08-01 | Ep Pharma, Llc | Low-temperature inhalation administration of cannabinoid entities |
US9833408B1 (en) * | 2016-07-28 | 2017-12-05 | Allen Greenspoon | Orally administrable formulation |
US10278951B1 (en) * | 2016-09-29 | 2019-05-07 | Jon Newland | Method of treating opiate dependency using tetrahydrocannabinol extracts |
KR20210040282A (ko) * | 2018-05-11 | 2021-04-13 | 로드스 테크놀로지즈 | 경구 전달용 조성물 및 투여 형태 |
US10888596B1 (en) | 2018-12-28 | 2021-01-12 | Cold Baked LLC | Method of preparing Cannabis extracts |
CN112237666B (zh) * | 2019-07-17 | 2022-06-17 | 东莞市爱的仕机电设备有限公司 | 一种雾化器及雾化器用的舌下喷嘴 |
US11497249B2 (en) | 2019-09-16 | 2022-11-15 | Vapor Cartridge Technology Llc | Drug delivery system with stackable substrates |
CN112755301B (zh) * | 2021-01-20 | 2022-03-29 | 孙洪坤 | 一种血液病造血干细胞移植用皮肤清洁器 |
EP4122439A1 (de) * | 2021-07-23 | 2023-01-25 | Bionorica SE | Verwendung von silikonisierten glasbehältern für flüssige pflanzenextrakte |
WO2024069423A1 (en) * | 2022-09-26 | 2024-04-04 | Feather Company Ltd. | Therapeutic formulation |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3836667A (en) * | 1972-03-24 | 1974-09-17 | Miles Lab | Method of producing bronchodilation |
BE793865A (fr) * | 1972-09-25 | 1973-07-10 | Syntex Corp | Composes d'acides xanthone-carboxyliques substitues par des groupes alcenyles et alcynyles |
US3836541A (en) * | 1972-09-27 | 1974-09-17 | Upjohn Co | 3-cyano-2-pyrryl oxamic acids |
US3937510A (en) | 1973-05-29 | 1976-02-10 | Lew Hyok S | Coupled chopsticks |
FR2313945A1 (fr) * | 1975-06-11 | 1977-01-07 | Fabre Sa Pierre | Appareil distributeur de medicaments se presentant sous la forme d'aerosols |
NZ194912A (en) | 1979-10-02 | 1983-05-31 | Beecham Group Ltd | 6 -(2-(2'-methylphenoxycarbonyl)-2-thien-3'-ylacetamido)-penicillanic acid and pharmaceutical compositions |
US4635651A (en) * | 1980-08-29 | 1987-01-13 | Jacobs Allen W | Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine |
EP0266443B1 (en) * | 1986-11-03 | 1993-06-23 | Allen W. Jacobs | Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine |
RU2005472C1 (ru) | 1988-02-29 | 1994-01-15 | Омский государственный ветеринарный институт | Способ профилактики неспецифической бронхопневмонии молодняка крупного рогатого скота |
DE68926717T2 (de) * | 1988-04-06 | 1997-01-23 | Mitsubishi Electric Corp | Optischer Abstandsdetektor |
US5248493A (en) * | 1988-08-27 | 1993-09-28 | Fisons Plc | Pharmaceutical composition |
JPH03153625A (ja) | 1989-11-13 | 1991-07-01 | Tsumura & Co | 抗アレルギー剤 |
JP3533228B2 (ja) * | 1993-02-23 | 2004-05-31 | トーアエイヨー株式会社 | 低刺激性ニトログリセリン組成物及びスプレー剤 |
CN1116104A (zh) | 1994-07-31 | 1996-02-07 | 禤卫年 | 百龄康饮品 |
CN1116101A (zh) | 1994-08-01 | 1996-02-07 | 程春桂 | 一种防治咳喘的保健用品及其制备方法 |
US5536749A (en) * | 1994-10-13 | 1996-07-16 | Sl Pharmaceuticals, Inc. | Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents |
WO1998024420A1 (en) * | 1996-12-04 | 1998-06-11 | Bioglan Ireland (R & D) Limited | Pharmaceutical compositions and devices for their administration |
US5976193A (en) * | 1997-04-08 | 1999-11-02 | Cigone Enterprises, Inc. | Method composition and system for removing |
GB9726916D0 (en) * | 1997-12-19 | 1998-02-18 | Danbiosyst Uk | Nasal formulation |
US6509005B1 (en) * | 1998-10-27 | 2003-01-21 | Virginia Commonwealth University | Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler |
US6846495B2 (en) * | 1999-01-11 | 2005-01-25 | The Procter & Gamble Company | Compositions having improved delivery of actives |
GB2337040B (en) * | 1999-06-21 | 2000-06-07 | Bespak Plc | Improvements in or relating to dispensing apparatus |
AU5958200A (en) * | 1999-07-08 | 2001-01-30 | Her Majesty The Queen As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government | Pulmonary delivery of liposome-encapsulated cannabinoids |
DE60023720T2 (de) * | 1999-08-20 | 2006-07-20 | Unimed Pharmaceuticals, Inc. | Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel |
CZ303537B6 (cs) | 2000-03-09 | 2012-11-21 | Gw Pharma Limited | Použití konopí pri príprave farmaceutické formulace a pumpickové sprejové zarízení |
SI1542657T1 (sl) | 2002-08-14 | 2012-04-30 | Gw Pharma Ltd | Kanabinoidne kapljevite formulacije za sluzniäśno administracijo |
-
2001
- 2001-03-09 CZ CZ20023017A patent/CZ303537B6/cs not_active IP Right Cessation
- 2001-03-09 AT AT01910026T patent/ATE353629T1/de active
- 2001-03-09 SI SI200130712T patent/SI1280515T1/sl unknown
- 2001-03-09 HU HU0300582A patent/HU228237B1/hu unknown
- 2001-03-09 ES ES01910026T patent/ES2280343T3/es not_active Expired - Lifetime
- 2001-03-09 MX MXPA02008778A patent/MXPA02008778A/es active IP Right Grant
- 2001-03-09 DE DE60126599T patent/DE60126599T2/de not_active Expired - Lifetime
- 2001-03-09 EP EP01910026A patent/EP1280515B1/en not_active Expired - Lifetime
- 2001-03-09 PL PL365005A patent/PL202673B1/pl unknown
- 2001-03-09 JP JP2001564742A patent/JP5599961B2/ja not_active Expired - Lifetime
- 2001-03-09 AU AU37608/01A patent/AU782991B2/en not_active Expired
- 2001-03-09 DK DK01910026T patent/DK1280515T3/da active
- 2001-03-09 KR KR1020027011818A patent/KR20030038536A/ko not_active Application Discontinuation
- 2001-03-09 NZ NZ544681A patent/NZ544681A/en not_active IP Right Cessation
- 2001-03-09 CN CNB018092640A patent/CN1258359C/zh not_active Expired - Lifetime
- 2001-03-09 US US10/221,066 patent/US20030191180A1/en not_active Abandoned
- 2001-03-09 IL IL15160301A patent/IL151603A0/xx active IP Right Grant
- 2001-03-09 CA CA002402020A patent/CA2402020C/en not_active Expired - Lifetime
- 2001-03-09 WO PCT/GB2001/001027 patent/WO2001066089A2/en active IP Right Grant
- 2001-03-09 PT PT01910026T patent/PT1280515E/pt unknown
-
2002
- 2002-09-04 IL IL151603A patent/IL151603A/en unknown
- 2002-09-04 NO NO20024222A patent/NO332663B1/no not_active IP Right Cessation
-
2007
- 2007-04-26 CY CY20071100569T patent/CY1106549T1/el unknown
- 2007-09-18 US US11/901,593 patent/US20080071233A1/en not_active Abandoned
-
2010
- 2010-08-10 US US12/853,387 patent/US20100323038A1/en not_active Abandoned
-
2011
- 2011-11-17 DE DE201112100060 patent/DE122011100060I1/de active Pending
-
2012
- 2012-09-07 US US13/606,742 patent/US8512767B2/en not_active Expired - Lifetime
- 2012-09-10 US US13/607,897 patent/US8481091B2/en not_active Expired - Lifetime
-
2013
- 2013-05-24 NO NO2013011C patent/NO2013011I2/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20024222D0 (no) | Farmasöytiske forbindelser | |
EA199900991A1 (ru) | Медицинские аэрозольные препараты | |
MXPA05001567A (es) | Formulaciones liquidas de canabinoides para la administracion a traves de la mucosa. | |
ES2079210T3 (es) | Formulacion farmaceutica de aerosol. | |
RS49803B (sr) | Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa | |
DK1303258T3 (da) | Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle | |
NO20000466L (no) | Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering | |
ES2134634T3 (es) | Composiciones farmaceuticas y dispositivos para su administracion. | |
NO20083759L (no) | Doserings aerosoler for administrering av farmasoytiske preparater | |
DK1161225T3 (da) | Doseringsaerosol med isobutan som drivmiddel | |
WO2003070194A3 (en) | Amino acid and peptide-modified forms of glucocorticoids | |
BR0303347A (pt) | Formulações de aerossol contendo ésteres de derivados de 3,17-diidroxi estratieno para deposição pulmonar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: SATIVEX; NAT. REG. NO/DATE: 11-8809 20120822; FIRST REG. NO/DATE: UK/H/2462/01/DC 20100616 Spc suppl protection certif: 2013011 Filing date: 20130524 |
|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: SATIVEX; NAT. REG. NO/DATE: MT NR. 11-8809 20120822; FIRST REG. NO/DATE: UK/H/2462/01/DC 20100616 Spc suppl protection certif: 2013011 Filing date: 20130524 Extension date: 20250616 |
|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: GW RESEARCH LIMITED, GB |
|
CREP | Change of representative | ||
CREP | Change of representative |
Representative=s name: BRYN AARFLOT AS, STORTINGSGATA 8, 0161 OSLO, NORGE |
|
MK1K | Patent expired |